Skip to content
Back to meeting Original
Madeleine Armstrong· @ByMadeleineA · X·· 1 day agoScore45
Body

Divarasib's benefit over approved KRAS G12C inhibitors is now clear, from the #ESMO26 abstract $RHHBY $AMGN $BMY

301 views · 5 likes · 2 reposts · 0 replies

Source: Madeleine Armstrong · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.